Literature DB >> 18294803

The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.

Michael T French1, Ioana Popovici, Lauren Tapsell.   

Abstract

Federal, state, and local government agencies require current and accurate cost information for publicly funded substance abuse treatment programs to guide program assessments and reimbursement decisions. The Center for Substance Abuse Treatment published a list of modality-specific cost bands for this purpose in 2002. However, the upper and lower values in these ranges are so wide that they offer little practical guidance for funding agencies. Thus, the dual purpose of this investigation was to assemble the most current and comprehensive set of economic cost estimates from the readily available literature and then use these estimates to develop updated modality-specific cost bands for more reasonable reimbursement policies. Although cost estimates were scant for some modalities, the recommended cost bands are based on the best available economic research, and we believe that these new ranges will be more useful to and pertinent for all stakeholders of publicly funded substance abuse treatment.

Mesh:

Year:  2008        PMID: 18294803      PMCID: PMC2614666          DOI: 10.1016/j.jsat.2007.12.008

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  27 in total

Review 1.  Is there a case for extended interventions for alcohol and drug use disorders?

Authors:  James R McKay
Journal:  Addiction       Date:  2005-11       Impact factor: 6.526

2.  Benefit-cost in the California treatment outcome project: does substance abuse treatment "pay for itself"?

Authors:  Susan L Ettner; David Huang; Elizabeth Evans; Danielle Rose Ash; Mary Hardy; Mickel Jourabchi; Yih-Ing Hser
Journal:  Health Serv Res       Date:  2006-02       Impact factor: 3.402

3.  Cost-effectiveness analysis of four interventions for adolescents with a substance use disorder.

Authors:  Michael T French; Silvana K Zavala; Kathryn E McCollister; Holly B Waldron; Charles W Turner; Timothy J Ozechowski
Journal:  J Subst Abuse Treat       Date:  2007-06-28

Review 4.  Economic costs of drug abuse: financial, cost of illness, and services.

Authors:  William S Cartwright
Journal:  J Subst Abuse Treat       Date:  2007-06-27

5.  A critical review of accounting and economic methods for estimating the costs of addiction treatment.

Authors:  William S Cartwright
Journal:  J Subst Abuse Treat       Date:  2007-07-05

6.  Organizational and client determinants of cost in outpatient substance abuse treatment.

Authors:  Aaron Beaston-Blaakman; Donald Shepard; Constance Horgan; Grant Ritter
Journal:  J Ment Health Policy Econ       Date:  2007-03

7.  Effectiveness and costs of inpatient versus day hospital cocaine rehabilitation.

Authors:  A I Alterman; C P O'Brien; A T McLellan; D S August; E C Snider; M Droba; J W Cornish; C P Hall; A H Raphaelson; F X Schrade
Journal:  J Nerv Ment Dis       Date:  1994-03       Impact factor: 2.254

8.  Cost-benefit analysis of drug treatment services: review of the literature*

Authors:  William S. Cartwright
Journal:  J Ment Health Policy Econ       Date:  2000-03-01

9.  Cost-effectiveness analysis of a brief intervention delivered to problem drinkers presenting at an inner-city hospital emergency department.

Authors:  F Michael Kunz; Michael T French; Shahrzad Bazargan-Hejazi
Journal:  J Stud Alcohol       Date:  2004-05

10.  Effectiveness and cost-effectiveness of four treatment modalities for substance disorders: a propensity score analysis.

Authors:  Ramin Mojtabai; Joshua Graff Zivin
Journal:  Health Serv Res       Date:  2003-02       Impact factor: 3.402

View more
  29 in total

1.  Introduction of the Tools for Economic Analysis of Patient Management Interventions in Heart Failure Costing Tool: a user-friendly spreadsheet program to estimate costs of providing patient-centered interventions.

Authors:  Shelby D Reed; Yanhong Li; Shital Kamble; Daniel Polsky; Felicia L Graham; Margaret T Bowers; Gregory P Samsa; Sara Paul; Kevin A Schulman; David J Whellan; Barbara J Riegel
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-12-06

2.  Evaluating Alternative Aftercare Models for Ex-Offenders.

Authors:  Leonard A Jason; Bradley D Olson; Ron Harvey
Journal:  J Drug Issues       Date:  2015-01

3.  The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders.

Authors:  Sarah Friedman; Haiyong Xu; Jessica M Harwood; Francisca Azocar; Brian Hurley; Susan L Ettner
Journal:  J Subst Abuse Treat       Date:  2017-06-26

4.  Monetary conversion factors for economic evaluations of substance use disorders.

Authors:  Kathryn McCollister; Xuan Yang; Bisma Sayed; Michael T French; Jared A Leff; Bruce R Schackman
Journal:  J Subst Abuse Treat       Date:  2017-07-18

Review 5.  Toward Addiction Prediction: An Overview of Cross-Validated Predictive Modeling Findings and Considerations for Future Neuroimaging Research.

Authors:  Sarah W Yip; Brian Kiluk; Dustin Scheinost
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-11-12

6.  The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?

Authors:  Sarah A Friedman; Francisca Azocar; Haiyong Xu; Susan L Ettner
Journal:  Drug Alcohol Depend       Date:  2018-07-19       Impact factor: 4.492

7.  The Brief Treatment Cost Analysis Tool (TCAT-Lite) for Substance Abuse Treatment: Reliability and Application.

Authors:  Donald S Shepard; Wu Zeng; Gail K Strickler; Aung K Lwin; Marion J Cros; Bryan R Garner
Journal:  Alcohol Treat Q       Date:  2012-10-12

8.  The cost of treating addiction from the client's perspective: results from a multi-modality application of the Client DATCAP.

Authors:  Kathryn E McCollister; Michael T French; Jeffrey M Pyne; Brenda Booth; Richard Rapp; Carey Carr
Journal:  Drug Alcohol Depend       Date:  2009-07-01       Impact factor: 4.492

9.  Paying for prevention: challenges to health insurance coverage for biomedical HIV prevention in the United States.

Authors:  Kristen Underhill
Journal:  Am J Law Med       Date:  2012

10.  Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial.

Authors:  Kathryn E McCollister; Michael T French; Derek M Freitas; Michael L Dennis; Christy K Scott; Rodney R Funk
Journal:  Addiction       Date:  2013-10-09       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.